Sido Muncul PT Cash Flow Conversion Efficiency
Sido Muncul PT cash flow conversion efficiency. Based on the latest financial reports, Sido Muncul PT (SIDO) has a cash flow conversion efficiency ratio of 0.055x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp165.95 Billion ≈ $9.72 Million USD) by net assets (Rp3.00 Trillion ≈ $175.51 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Sido Muncul PT (2010–2025)
Cash flow conversion efficiency of Sido Muncul PT from 2010 to 2025. This chart illustrates how Sido Muncul PT's cash flow conversion efficiency has evolved over time, based on yearly financial data. View SIDO live share price for real-time trading data and today's change.
Sido Muncul PT Cash Flow Conversion Ratio Explained
Sido Muncul PT cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Sido Muncul PT Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sido Muncul PT ranked by their cash flow conversion efficiency. Also see Sido Muncul PT stock valuation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Nuveen Dynamic Municipal Opportunities Fund
NYSE:NDMO
|
0.036x |
|
EXPLOS. PROD. CHIM.EO 31
F:9Z50
|
N/A |
|
HANA Micron Inc
KQ:067310
|
-0.039x |
|
BEIJ.JINGNENG CL.ERG.HYC1
F:BJ6
|
N/A |
|
Sansec Technology Co. Ltd. A
SHG:688489
|
N/A |
|
Lionco Pharm Grp Co Ltd
SHG:603669
|
-0.123x |
|
Hangzhou Zhengqiang Corporation Limited
SHE:301119
|
0.045x |
|
Rashtriya Chemicals and Fertilizers Limited
NSE:RCF
|
0.253x |
Annual Cash Flow Conversion Efficiency for Sido Muncul PT (2010–2025)
The table below shows the annual cash flow conversion efficiency of Sido Muncul PT from 2010 to 2025. Review Sido Muncul PT (SIDO) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Rp3.12 Trillion ≈ $182.85 Million |
Rp1.25 Trillion ≈ $73.44 Million |
0.402x | +21.73% |
| 2024-12-31 | Rp3.49 Trillion ≈ $204.37 Million |
Rp1.15 Trillion ≈ $67.44 Million |
0.330x | +5.87% |
| 2023-12-31 | Rp3.39 Trillion ≈ $198.40 Million |
Rp1.06 Trillion ≈ $61.84 Million |
0.312x | -1.67% |
| 2022-12-31 | Rp3.51 Trillion ≈ $205.41 Million |
Rp1.11 Trillion ≈ $65.11 Million |
0.317x | -8.25% |
| 2021-12-31 | Rp3.47 Trillion ≈ $203.40 Million |
Rp1.20 Trillion ≈ $70.28 Million |
0.346x | +7.47% |
| 2020-12-31 | Rp3.22 Trillion ≈ $188.78 Million |
Rp1.04 Trillion ≈ $60.69 Million |
0.321x | +17.73% |
| 2019-12-31 | Rp3.06 Trillion ≈ $179.58 Million |
Rp836.91 Billion ≈ $49.04 Million |
0.273x | +7833.63% |
| 2018-12-31 | Rp2.90 Trillion ≈ $170.08 Million |
Rp9.99 Billion ≈ $585.43K |
0.003x | -2.25% |
| 2017-12-31 | Rp2.90 Trillion ≈ $169.69 Million |
Rp10.20 Billion ≈ $597.50K |
0.004x | -44.67% |
| 2016-12-31 | Rp2.76 Trillion ≈ $161.60 Million |
Rp17.55 Billion ≈ $1.03 Million |
0.006x | +3.12% |
| 2015-12-31 | Rp2.60 Trillion ≈ $152.25 Million |
Rp16.04 Billion ≈ $939.65K |
0.006x | +124.28% |
| 2014-12-31 | Rp2.63 Trillion ≈ $154.38 Million |
Rp7.25 Billion ≈ $424.82K |
0.003x | +48.17% |
| 2013-12-31 | Rp2.63 Trillion ≈ $153.84 Million |
Rp4.88 Billion ≈ $285.71K |
0.002x | +133.65% |
| 2012-12-31 | Rp1.30 Trillion ≈ $76.45 Million |
Rp1.04 Billion ≈ $60.76K |
0.001x | -59.05% |
| 2011-12-31 | Rp535.34 Billion ≈ $31.37 Million |
Rp1.04 Billion ≈ $60.88K |
0.002x | -55.18% |
| 2010-12-31 | Rp346.41 Billion ≈ $20.30 Million |
Rp1.50 Billion ≈ $87.89K |
0.004x | -- |
About Sido Muncul PT
PT Industri Jamu dan Farmasi Sido Muncul Tbk provides herbal medicines, cosmetics, and foods and beverage products in Indonesia. The company operates through three segments: Herbal Medicine and Supplements; Food and Beverage; and Pharmacy. It also offers medicine products comprising ethical/prescriptions and OTCs; herbal products, such as traditional herbals, food and beverages, herbal medicines,… Read more